Literature DB >> 12032097

The American Diabetes Association and World Health Organization classifications for diabetes: their impact on diabetes prevalence and total and cardiovascular disease mortality in elderly Japanese-American men.

Beatriz L Rodriguez1, Robert D Abbott, Wilfred Fujimoto, Beth Waitzfelder, Randi Chen, Kamal Masaki, Irwin Schatz, Helen Petrovitch, Webster Ross, Katsuhiko Yano, Patricia L Blanchette, J David Curb.   

Abstract

OBJECTIVE: To compare the prevalence of diabetes according to the American Diabetes Association (ADA) and World Health Organization (WHO) classifications in a sample of elderly Japanese-American men; to examine the association with total and cardiovascular mortality by diabetes status using both classifications; and to determine whether the fasting or 2-h glucose measurement is a stronger predictor of adverse outcomes. RESEARCH DESIGN AND METHODS: Examinations given from 1991 to 1993 in the Honolulu Heart Program were used as baseline for these analyses. Subjects were 71-93 years of age at that time and were followed for total and cardiovascular disease mortality for up to 7 years.
RESULTS: A total of approximately 66% of individuals who had diabetes by WHO criteria were missed when the ADA definition was used. The relative risks of total and cardiovascular mortality for those with versus those without diabetes were similar for both definitions; however, when fasting and postload glucose measures were analyzed as continuous variables, the 2-h measurement was a superior predictor and was independent of fasting glucose. In contrast, fasting glucose was not an independent predictor of these outcomes in the presence of the 2-h measurement.
CONCLUSIONS: The prevalence of glucose metabolism abnormalities was very high among elderly Japanese-American men. The WHO classification was superior to the ADA classification in identification of subjects at high risk for adverse outcomes. Therefore, we conclude that the 2-h glucose measurement is valuable and should be retained in epidemiologic studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032097     DOI: 10.2337/diacare.25.6.951

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  20 in total

1.  Linkage and association analyses of type 2 diabetes/impaired glucose metabolism and adiponectin serum levels in Japanese Americans from Hawaii.

Authors:  Ilija P Kovac; Richard J Havlik; Daniel Foley; Rita Peila; Dena Hernandez; Fabienne Wavrant-De Vrièze; Andrew Singleton; Josephine Egan; Dennis Taub; Beatriz Rodriguez; Kamal Masaki; J David Curb; Wilfred Y Fujimoto; Alexander F Wilson
Journal:  Diabetes       Date:  2007-02       Impact factor: 9.461

2.  Hyperglycemia alters mitochondrial fission and fusion proteins in mice subjected to cerebral ischemia and reperfusion.

Authors:  Santosh Kumari; Lavita Anderson; Stephanie Farmer; Suresh L Mehta; P Andy Li
Journal:  Transl Stroke Res       Date:  2012-06       Impact factor: 6.829

3.  Protein Glycosylation in Diabetes.

Authors:  Tamara Štambuk; Olga Gornik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

4.  Use of the dietary supplement 5-aminiolevulinic acid (5-ALA) and its relationship with glucose levels and hemoglobin A1C among individuals with prediabetes.

Authors:  Beatriz L Rodriguez; J David Curb; James Davis; Terry Shintani; Michael H Perez; Noelani Apau-Ludlum; Crystal Johnson; Rosanne C Harrigan
Journal:  Clin Transl Sci       Date:  2012-06-01       Impact factor: 4.689

5.  FOXO3A genotype is strongly associated with human longevity.

Authors:  Bradley J Willcox; Timothy A Donlon; Qimei He; Randi Chen; John S Grove; Katsuhiko Yano; Kamal H Masaki; D Craig Willcox; Beatriz Rodriguez; J David Curb
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-02       Impact factor: 11.205

6.  Diabetes prevalence and body mass index differ by ethnicity: the Multiethnic Cohort.

Authors:  Gertraud Maskarinec; Andrew Grandinetti; Grace Matsuura; Sangita Sharma; Marjorie Mau; Brian E Henderson; Laurence N Kolonel
Journal:  Ethn Dis       Date:  2009       Impact factor: 1.847

7.  Heart rate-corrected QT interval in resting ECG predicts the risk for development of type-2 diabetes mellitus.

Authors:  Teruo Nagaya; Hideyo Yoshida; Hidekatsu Takahashi; Makoto Kawai
Journal:  Eur J Epidemiol       Date:  2010-03       Impact factor: 8.082

8.  A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels.

Authors:  Sven Schinner; Reiner Füth; Kerstin Kempf; Stephan Martin; Holger S Willenberg; Matthias Schott; Wilfried Dinh; Werner A Scherbaum; Mark Lankisch
Journal:  Cardiovasc Diabetol       Date:  2011-06-24       Impact factor: 9.951

9.  An evaluation of glucose tolerance in essential hypertension.

Authors:  Armagan Tugrul; Sibel Guldiken; Betul Ugur-Altun; Ender Arikan
Journal:  Yonsei Med J       Date:  2009-04-30       Impact factor: 2.759

10.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.